Streamline Health Solutions, Inc.
Streamline Health Solutions, Inc. (STRM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
strm · stock forecast · 3 analysts (3M) · FMP · updated Nov 18, 2025
Analyst Rating & Consensus
Based on 3 Wall Street analysts in the past 3 months
Buy
3 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $5.33
Short-Term Price Prediction
RangingAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $5.34 | ↑ 0.11% |
1-day model range: $5.33–$5.34. Peak: $5.34 (+0.11%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · STRM · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-05-20 | Lake Street | Maintains | Buy→Buy |
| 2016-04-25 | Lake Street | Downgrade ↓ | Buy→Hold |
| 2015-09-04 | Cowen & Co. | Maintains | Outperform→Outperform |
| 2014-02-04 | Lake Street | Maintains | Buy→Buy |
| 2013-12-03 | Avondale Partners | Maintains | Market Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Streamline Health Solutions, Inc. (STRM) stock. Of the recent 5 rating actions, 0 were upgrades and 1 were downgrades. 3 analysts currently cover STRM.
Analyst Recommendation Trends
STRM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$25M
↑ 23.8% YoY
Revenue Next Year
$20M
↓ 18.0% YoY
EPS This Year
$-3.67
EPS Next Year
$-4.87
↑ 32.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast STRM EPS of $-3.67 for the current fiscal year, based on estimates from 1 analysts. The STRM revenue forecast is $25M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The STRM stock forecast is supported by two independent data sources: analyst consensus ratings from 3 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus STRM price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The STRM short-term stock prediction for tomorrow is $5.34 (+0.11%).
Streamline Health Solutions, Inc. trades on NASDAQ under the ticker STRM. The STRM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
STRM forecast · 8 questionsAccording to 3 Wall Street analysts, the average 12-month STRM price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $5.33.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.